Phase 2 clinical pharmacology study in nmDMD patients to assess dystrophin levels in patients with nmDMD who have been treated with ataluren

Project: Research project

Project Details

Description

Phase 2 clinical pharmacology study in nmDMD patients to assess dystrophin levels in patients with nmDMD who have been treated with ataluren
StatusActive
Effective start/end date12/1/1811/30/23

Funding

  • PTC Therapeutics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.